Patrick G. Lepore, Director at Matinas BioPharma Holdings, Inc. (MTNB), bought 100,000 shares at $0.72 ($72K) on 2019-08-16, disclosed to the SEC on 2019-08-20.
Open-market purchase of $72k MTNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| VYNE | BUY | 2023-03-22 | $50K | — | Filing → |
| LCI | BUY | 2022-11-14 | $49K | — | Filing → |
| LCI | BUY | 2022-05-17 | $27K | — | Filing → |